Clinical Trials List
2023-12-24 - 2027-03-01
Phase II
Recruiting5
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- Yu-Min Yeh Division of Hematology & Oncology
- Chin-Wei Kuo 無
- Wu-Chou Su Division of Hematology & Oncology
- Chien-Chung Lin 無
- Shang-Yin Wu Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Seu-Chun Yang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YEN-HAN TSENG
- 廖映庭 Division of Thoracic Medicine
- Chia-I Shen
- 蕭慈慧 Division of Thoracic Medicine
- Chi-Lu Chiang
- Heng-Sheng Chao Division of Thoracic Medicine
- Yuh-Min Chen
- Hsu-ching Huang Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳俊漢醫師 Division of Thoracic Medicine
- 陳昱光醫師
- 黃才旺醫師 Division of Thoracic Surgery
- 蔡鎮良 Division of Thoracic Medicine
- 吳世偉 Division of Thoracic Medicine
- 柯凱雄醫師
- 彭忠衎 Division of Thoracic Medicine
- 劉佳鑫醫師 Division of Thoracic Medicine
- 賴學緯醫師 Division of Hematology & Oncology
- 王勝輝醫師 Division of Thoracic Medicine
- 孟繁俊醫師 Division of Thoracic Medicine
- 陳盈潔醫師 Division of Thoracic Medicine
- 葉人華 Division of Hematology & Oncology
- 鄭立廷醫師 Division of Thoracic Medicine
- 吳宜穎
- 陳佳宏
- 黃子權 Division of Hematology & Oncology
- 蔡文銓醫師 Division of Others
- 簡志峯醫師 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
90 participants